Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 2:24 PM ET

Capital Markets

Company Overview of Canaccord Genuity Inc.

Company Overview

Canaccord Genuity Inc. is an investment banking firm that provides financial advisory services. The firm offers mergers and acquisitions advisory, divestitures, recapitalizations, valuations, fairness opinions, private placements, private capital raising, and valuation analysis services. Additionally, it provides underwriting, Initial Public Offering (IPO), and equity sales and trading services. The firm caters to metals and mining, energy, technology, telecommunications, life sciences, real estate, and aerospace industries. Canaccord Adams, formerly known as Adams Harkness, Inc., was founded in 1969 and is based in Boston, Massachusetts with additional offices across the United States. Cana...

99 High Street

Suite 1200

Boston, MA 02110

United States

Founded in 1969



Key Executives for Canaccord Genuity Inc.

Chief Financial Officer and Treasurer
Managing Director
Managing Director of Capital Markets
Compensation as of Fiscal Year 2015.

Canaccord Genuity Inc. Key Developments

Muscle Pharm To Sell Stakes In BioZone Laboratories

Muscle Pharm Corp. (OTCPK:MSLP) to explore the sale of all or substantially all of the assets of BioZone Laboratories Inc. MusclePharm Corporation announced that it has retained an Genuity Inc. to explore the sale of all or substantially all of the assets of its BioZone Laboratories Inc. Ryan Drexler, Executive Chairman of Muscle Pharm, said, “We remain committed to acting in the best interests of our shareholders and further maximizing shareholder value. At the end of the day, we are a sales and marketing company, and that is where we want to focus. As a result, we are going to concentrate on our core competencies while leaving other aspects of the business to strategic partners or outside parties who can bring more expertise to those areas than us. As part of this process, MusclePharm has retained investment bank Canaccord Genuity Inc. to advise the Board of Directors and management with respect to a sale.” The Company said there can be no assurance that its evaluation process will result in any transaction or that any transaction, if pursued, will be consummated.

SynCardia Hires Canaccord To Consider Strategic Alternatives

SynCardia Systems, Inc. has initiated a process to explore and evaluate all potential strategic alternatives to maximize stakeholder value, including a possible sale of the business. Michael Garippa, SynCardia Chief Executive Officer, said "SynCardia develops and manufactures the only FDA and CE Mark Total Artificial Heart, an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia Board of Directors has retained Canaccord Genuity to evaluate and identify strategic alternatives aimed at optimizing the value of our business and technology, which have resulted in over 1,500 implants of our Total Artificial Heart in patients globally.” Conaccord Genuity Inc. has been hired by SynCardia to explore and evaluate all potential strategic alternatives.

Canaccord Genuity Appoints Blake Tennant as Managing Director, Industrials and Infrastructure Services

Canaccord Genuity announced that Blake Tennant has joined its investment banking team as Managing Director, Industrials and Infrastructure Services. Mr. Tennant will be based in Washington, DC and will focus on leveraging Canaccord Genuity's global capabilities to deliver a broad range of investment banking services, including public offerings, private placements, and mergers and acquisitions advisory services. Mr. Tennant joins Canaccord Genuity from FBR Capital Markets, where he spent the past 9 years, most recently as a Managing Director, and Head of Infrastructure Investment Banking.

Similar Private Companies By Industry

Company Name Region
Antares Capital Partners III, L.L.C. United States
JMP GROUP INC. United States
AVM, L.P. United States
InterOcean Advisors LLC United States
Paragon Energy Holdings, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Canaccord Genuity Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at